Intellectus Partners’s AbbVie ABBV Stock Holding History

Intellectus Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.14M	Buy	6,137 +2	+0%	+$371	0.25%	113
2025 Q1	$1.29M	Buy	6,135 +9	+0.1%	+$1.89K	0.32%	94
2024 Q4	$1.09M	Sell	6,126 -5	-0.1%	-$889	0.24%	106
2024 Q3	$1.21M	Sell	6,131 -4,408	-42%	-$871K	0.31%	96
2024 Q2	$1.81M	Buy	10,539 +4,931	+88%	+$846K	0.49%	57
2024 Q1	$1.02M	Sell	5,608 -7,187	-56%	-$1.31M	0.27%	106
2023 Q4	$1.98M	Sell	12,795 -37	-0.3%	-$5.73K	0.57%	50
2023 Q3	$1.91M	Sell	12,832 -13	-0.1%	-$1.94K	0.61%	45
2023 Q2	$1.73M	Buy	12,845 +27	+0.2%	+$3.64K	0.52%	49
2023 Q1	$2.04M	Buy	12,818 +1,598	+14%	+$255K	0.65%	43
2022 Q4	$1.81M	Buy	11,220 +58	+0.5%	+$9.37K	0.63%	44
2022 Q3	$1.5M	Sell	11,162 -346	-3%	-$46.4K	0.53%	53
2022 Q2	$1.76M	Sell	11,508 -800	-6%	-$123K	0.61%	42
2022 Q1	$2M	Buy	12,308 +2,845	+30%	+$461K	0.6%	43
2021 Q4	$1.28M	Sell	9,463 -20	-0.2%	-$2.71K	0.33%	80
2021 Q3	$1.02M	Buy	9,483 +173	+2%	+$18.7K	0.25%	108
2021 Q2	$1.05M	Buy	9,310 +5,075	+120%	+$572K	0.24%	116
2021 Q1	$458K	Sell	4,235 -7,994	-65%	-$865K	0.13%	185
2020 Q4	$1.31M	Sell	12,229 -660	-5%	-$70.7K	0.39%	78
2020 Q3	$1.13M	Sell	12,889 -1,984	-13%	-$174K	0.43%	70
2020 Q2	$1.46M	Buy	+14,873	New	+$1.46M	0.57%	43
2020 Q1	–	Sell	-12,191	Closed	-$1.08M	–	194
2019 Q4	$1.08M	Buy	12,191 +404	+3%	+$35.8K	0.44%	63
2019 Q3	$893K	Buy	11,787 +2,313	+24%	+$175K	0.39%	75
2019 Q2	$689K	Buy	9,474 +1,200	+15%	+$87.3K	0.3%	97
2019 Q1	$667K	Buy	8,274 +1,625	+24%	+$131K	0.29%	99
2018 Q4	$613K	Sell	6,649 -803	-11%	-$74K	0.42%	62
2018 Q3	$705K	Buy	7,452 +651	+10%	+$61.6K	0.25%	117
2018 Q2	$630K	Buy	6,801 +1,175	+21%	+$109K	0.23%	117
2018 Q1	$533K	Buy	5,626 +4,314	+329%	+$409K	0.18%	131
2017 Q4	$127K	Hold	1,312	–	–	0.05%	262
2017 Q3	$117K	Hold	1,312	–	–	0.05%	279
2017 Q2	$95K	Buy	1,312 +378	+40%	+$27.4K	0.04%	277
2017 Q1	$61K	Hold	934	–	–	0.03%	300
2016 Q4	$58K	Buy	+934	New	+$58K	0.03%	294